Nicotinamide Adenine Dinucleotide (NAD+) is a coenzyme that plays a crucial role in energy metabolism and is involved in various cellular processes. In recent years, there has been an increasing interest in NAD+ due to its potential therapeutic applications in various health conditions, including aging, neurodegenerative diseases, cancer, metabolic disorders, and more. The global NAD+ market is expected to witness significant growth in the coming years, driven by various factors, such as the growing demand for NAD+ supplements, increasing research and development activities, and the rising prevalence of chronic diseases.
Market Overview The global NAD+ market is estimated to be valued at USD 230 million in 2020 and is expected to grow at a CAGR of 10.5% during the forecast period of 2021-2026. The market is segmented by product type, application, and end-user.
Based on product type, the market is segmented into supplements, injections, and intermediates. The supplement segment is expected to dominate the market, owing to the growing demand for NAD+ supplements as a potential anti-aging and wellness solution. The injection segment is also expected to witness significant growth, primarily driven by the potential therapeutic applications of NAD+ injections in treating various health conditions.
Based on application, the market is segmented into anti-aging, neurodegenerative diseases, cancer, metabolic disorders, and others. The anti-aging segment is expected to dominate the market, owing to the growing demand for NAD+ supplements as a potential anti-aging and wellness solution. The neurodegenerative diseases segment is also expected to witness significant growth, primarily driven by the potential therapeutic applications of NAD+ in treating neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The cancer segment is also expected to witness significant growth, driven by the potential therapeutic applications of NAD+ in cancer treatment.
Based on end-user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and others. The pharmaceutical and biotechnology companies segment is expected to dominate the market, owing to the increasing research and development activities in the NAD+ field by pharmaceutical and biotechnology companies.
Regional Analysis North America is expected to dominate the global NAD+ market, owing to the increasing prevalence of chronic diseases, such as cancer, neurodegenerative diseases, and metabolic disorders, and the growing demand for NAD+ supplements as a potential anti-aging and wellness solution. The Asia Pacific is expected to witness significant growth in the coming years, primarily driven by the increasing awareness about the potential health benefits of NAD+ supplements and the growing demand for NAD+ in cancer treatment.
Key Players The global NAD+ market is highly competitive, with several players operating in the market. Some of the key players in the market include ChromaDex, Inc., Elysium Health, Inc., High Performance Nutrition, LLC, Live Cell Research, Longevity Plus, Metabolic Maintenance Products, Inc., ProHealth, and Thorne Research, Inc.
Growth Drivers The global NAD+ market is expected to witness significant growth in the coming years, driven by various factors, such as the growing demand for NAD+ supplements, increasing research and development activities, and the rising prevalence of chronic diseases.
The increasing demand for NAD+ supplements is primarily driven by the growing awareness about the potential health benefits of NAD+ supplements in anti-aging and wellness. NAD+ supplements are known to improve cellular function, enhance metabolism, and promote healthy aging, making them a popular choice among consumers.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Everest Market Insights journalist was involved in the writing and production of this article.
